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Abstract 
We investigated the mechanisms of [3H]-L-arginine transport via System y+ using plasma membrane vesicles derived 
from cultured pulmonary artery endothelial cells. [3H]-L-arginine uptake into plasma membrane vesicles was Na-indepen- 
dent, sensitive to trans-stimulation, u affected by proton-conducting ionophores, and selectively inhibited by cationic amino 
acids. Kinetic experiments performed over a wide range of substrate concentrations revealed only one population of 
L-arginine transporters with K~ = 130 IxM. To elucidate the driving force for L-arginine transport, we measured [3H]-L- 
arginine uptake by plasma membrane vesicles at different ransmembrane ion gradients. Plasma membrane vesicles 
accumulated [3H]-L-arginine only when a membrane potential was imposed across the vesicles, and the velocity of uptake 
was linearly related to the magnitude of the created membrane potential. The presence of potassium ions inside the vesicles 
was not essential for uptake of L-arginine into vesicles, but it was essential for trans-stimulation f L-arginine transport. 
[3H]-L-arginine accumulated in plasma membrane vesicles can be released by agents that dissipate transmembrane 
potassium gradients (e.g. saponin, gramicidin, and nigericin). Diazoxide and pinacidil, activators of K+-channels, had no 
significant effect on [3H]-L-arginine uptake, whereas tetraethylammonium chloride, 4-aminopyridine, and glibenclamide, 
inhibitors of K+-channels, caused decreases in [3H]-L-arginine transport by plasma membrane vesicles. This study 
demonstrates for the first time a specific role for potassium ions in the mechanism of L-arginine transport, particularly in the 
phenomenon of trans-stimulation. Published by Elsevier Science B.V. 
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1. In t roduct ion  
The cationic amino-acid L-arginine is the main 
source for the synthesis of nitric oxide (NO) in many 
cell types [1,2]. Vascular endothelial cells synthesize 
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NO via a calcium/calmodulin-dependent constitutive 
NO synthase (eNOS; ecNOS: Type III NOS) [3]. The 
K m of eNOS for L-arginine is < 10 ~M [4,5], and 
several studies have reported values for intracellular 
L-arginine content in cultured endothelial cells that 
range from 0.1 to 0.8 mM [6-8]. Therefore, eNOS 
would be expected to be saturated with L-arginine 
under physiological conditions. However, a number 
of in-vitro and in-vivo studies indicate that NO pro- 
duction by vascular endothelial cells under physio- 
logical conditions can be increased by exogenous 
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L-arginine [9-11]. These studies uggest that extracel- 
lular L-arginine and/or its transport into endothelial 
cells play important, and as yet undefined, roles in 
NO production by the vascular endothelium. 
There are four physiological transport systems (y +, 
b °'+, B °'+, and y+L) that can mediate L-arginine 
transport across plasma membranes in different cell 
types [12]. The majority, i.e. 60-80%, of L-arginine 
transport by pulmonary artery endothelial cells 
(PAEC) is mediated by the sodium-independent y+ 
transport system [13-16]. At present, three members 
of a family of cationic amino acid transporters (CAT1, 
CAT2, and CAT2a) with System y+ transport activ- 
ity have been cloned [17]. Although they share a 
common substrate specificity, the tissue specific ex- 
pression and the role of these proteins in metabolism 
differ. In voltage-clamped Xenopus oocytes injected 
with CAT1 cRNA, it was demonstrated that proper- 
ties of the CATl-mediated uptake of L-arginine 
[18,19] were consistent with the transport properties 
of System y+, described in endothelial cells [15,16]. 
An extensive review of System y+ characteristics 
is published elsewhere [20]. Two distinctive features 
of System y+ are: 
1. transport activity is sensitive to changes in extra- 
cellular K +, suggesting that L-arginine influx is 
influenced by membrane potential [14,19,21,22], 
and 
2. L-arginine uptake via System y+ is subject to 
trans-stimulation when substrate concentrations are 
sufficiently high on the opposite side of the mem- 
brane. 
However, the detailed mechanisms of these phenom- 
ena of L-arginine transport via System y+ in endothe- 
lial cells have not been fully defined. This study 
describes ome properties and characteristics of L- 
arginine transport by plasma membrane vesicles de- 
rived from cultured PAEC. Membrane vesicles iso- 
lated from mammalian cells have proved extremely 
useful for the study of transport processes. Some of 
their advantages include the ability to use well-de- 
fined ion gradients and the lack of metabolism of the 
transported substance. Thus, the transport process 
may be studied in isolation from other cellular pro- 
cesses. In the present investigation, we examined the 
effect of ion gradients in the absence of any exoge- 
nous energy source on L-arginine transport by en- 
dothelial cell plasma membrane vesicles. 
2. Materials and methods 
2.1. Tissue culture 
Endothelial cells were obtained from the main 
pulmonary artery of 6- to 7-month-old pigs and were 
cultured as previously reported [13]. Third- to sev- 
enth-passage PAEC in monolayer culture maintained 
in RPMI-1640 medium plus 4% fetal bovine serum 
and 100 U/ml  penicillin, 100 ixg/ml streptomycin, 
20 Ixg/ml gentamicin, and 2 ixg/ml fungizone were 
used for all experiments. Cells were identified and 
characterized as pure endothelial monolayers as pre- 
viously described [13]. 
2.2. Preparation of membrane vesicles 
The preparation was based on the procedure de- 
scribed by Teitel [23] and modified by Bhat and 
Block [24]. This procedure yields a preparation that is 
free of mitochondria and microsomes and has 15-fold 
enrichment of Na-K ATPase activity [24,25]. Mono- 
layer cultures were scraped with a large rubber spat- 
ula into precooled Hanks' balanced salt solution 
(HBSS). All subsequent operations were at 4°C. The 
cell suspension was centrifuged at 800 × g for 15 to 
20min, resuspended in Buffer A (0.25M sucrose, 
0.2mM MgSO 4, 10raM HEPES-Tris (pH 7.4)), and 
centrifuged again. The cell pellet was resuspended at
a ratio of 1:9 :: pellet:Buffer A v/v,  and the cells 
were disrupted by nitrogen cavitation using a pre- 
cooled minicell disruptor. Nitrogen pressure was 600 
to 700 psi. After 15 min under pressure, the suspen- 
sion was delivered dropwise from the instrument. 
Then the broken cell suspension was centrifuged at 
2000 X g for 5 min to remove nuclei, large aggre- 
gates, and broken cells. The postnuclear supernatant 
was centrifuged for 20 min at 85 000 × g. The result- 
ing pellet was resuspended in Buffer A and layered 
over a discontinuous (15, 30 and 45%) sucrose gradi- 
ent. The gradient was centrifuged at 100000 × g for 
1 h at 4°C. The bands at 15 and 30% sucrose interface 
were collected, diluted with cold 10 mM HEPES-Tris 
(pH 7.4), and centrifuged at 85 000 X g for 20 min. 
The final pellet of plasma membrane vesicles was 
suspended in Buffer A at a concentration of 3-5 mg 
of membrane protein/ml, frozen in liquid nitrogen, 
and stored at -80°C. Transport activity was stable 
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for at least one month under these conditions. Purity 
of the preparation was confirmed by electron mi- 
croscopy. 
2.3. Transport assays 
Transport assays were performed essentially as 
described by Rudnick [26] and modified by Bhat and 
Block [24,25]. Membranes in Buffer A were rapidly 
thawed at 37°C and diluted into at least 10 volumes 
of a loading solution. After incubation for 30 min at 
4°C, the suspension was centrifuged at 48000 X g 
for 15 min, and the pellet was resuspended in loading 
solution to a final concentration of 2-3 mg 
protein/ml. The composition of the loading solution 
was 140 mM potassium phosphate (pH 6.8) and 1 mM 
MgSO4, unless stated otherwise. The resuspended 
pellet solution (30 Ixl) was added to 470 Ixl of exter- 
nal solution containing 140 mM LiC1 + 1 mM MgSO 4 
in 10raM HEPES-Tris, pH 7.4, and 50~M [3H]-L- 
arginine (= 2000 dpm/pmol) unless indicated other- 
wise. Inhibitors and ionophores, when present, were 
usually added to the external solution prior to the 
addition of the membrane vesicles. After incubation 
for specific times at 37°C, reactions were terminated 
by the addition of 5 ml of ice-cold 0.15 M LiC1 (stop 
solution) followed by filtration through fiberglass 
Whatman GF/C  filters presoaked in 0.5% polyeth- 
ylenimine. The filters were washed four times with 
5 ml of washing solution, dried, and counted using 
liquid scintillation spectrometry. Zero-time blank val- 
ues (membrane vesicles added after stop solution) 
were subtracted from all experimental values. 
counted using liquid scintillation spectrometry. In- 
travesicular water space was calculated from the slope 
of the line of the dependence of the equilibrium 
[14C]-3-MG uptake plotted as a function of substrate 
concentration. The total intravesicular space deter- 
mined in this manner was found to be 1.14+ 
0.16 Ixl/mg protein. 
2.5. [ 3H]-Ouabain binding 
[3H]-Ouabain binding was used to test the orienta- 
tion of vesicles. Ouabain will only bind with high 
affinity to right-side-out vesicles if they are relatively 
impermeable to small molecules, and to right-side-out 
as well as inside-out vesicles if they are leaky or 
broken, or else after permeabilization f vesicles with 
saponin. Plasma membrane vesicles loaded with 
140mM potassium phosphate (pH 6.8) and l mM 
MgSO 4 (30txl) were incubated with [3H]-ouabain 
(80 nM) in the external solution (final volume 0.5 ml) 
containing 140 mM LiC1 and 1 mM MgSO 4 
(HEPES-Tris buffer, pH 7.4) for 30 min at 37°C. The 
binding reaction was terminated by addition of the 
ice-cold external solution followed by filtration 
through fiberglass Whatman GF/C filters. After 
washing and drying, the filters were counted using 
liquid scintillation spectrometry. The nonspecific 
binding of [3H]-ouabain was determined in the pres- 
ence of 1 mM unlabeled ouabain and was subtracted 
from the experimental values. The same experiments 
were performed on plasma membrane vesicles treated 
with saponin (501~g/ml). The analysis of [3H]- 
ouabain binding indicated that 80 _+ 5% of the vesi- 
cles were in a right-side-out orientation. 
2.4. Intravesicular uolume measurement 
2.6. Protein determinations 
Intravesicular volume was determined, using 3-0- 
methyl-[HC]-D-glucose (3-MG), according to the 
method described by Kletzien et al. [27]. Membrane 
preparations (50-100 Ixg of protein) were incubated 
for 30 min at 37°C with concentrations of [ HC]-3-MG 
ranging from 0.026 to 1.04mM. [14C]-3-MG uptake 
was terminated by the addition of an ice-cold isos- 
motic solution of NaC1 followed by filtration and 
washing the filter four times with 5 ml of the same 
solution. The radioactivity of the dried filters was 
Protein was determined by the method of Lowry et 
al. [28] using albumin as a standard. 
2.7. Statistical analysis 
Data are presented as means + SE. Student's un- 
paired t-tests were used to determine the significance 
of differences between means, and P < 0.05 was 
considered significant. 
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3. Results 
3.1. Characterization f the uptake of [ ~H]-L-arginine 
into plasma membrane vesicles 
The data presented in Fig. 1 illustrate the uptake of 
[3 H]-L-arginine into PAEC-derived plasma membrane 
vesicles uspended in different extracellular solutions. 
The maximal velocity of uptake was observed in 
plasma membrane vesicles loaded with potassium 
phosphate buffer and diluted 16-fold into NaC1 solu- 
tion containing [3H]-L-arginine. Nearly all of the 
[3H]-L-arginine was transported in a Na-independent 
manner, because substitution of Li + or choline ions 
in the external solution for Na + ions resulted in only 
a 6% reduction in [3H]-L-arginine uptake by plasma 
membrane vesicles (Fig. 1 and Table 1). Substitution 
of Li ÷ or choline for Na + in the transport assays 
yielded the same values for [3H]-L-arginine uptake in 
plasma membrane vesicles. This is in good agreement 
with data in intact PAEC [15]. 
To verify that the Na-independent uptake of L- 
arginine was being mediated exclusively by System 
y÷, as opposed to System y+L, which also transports 
L-arginine in the absence of sodium [12,29], we 
measured L-arginine uptake in the presence of 100 p~M 
leucine. This concentration of leucine has been re- 
ported to inhibit uptake by System y+L without 
affecting uptake by System y+ [12,17]. As shown in 
Table 2, 100 la, M leucine had no effect on L-arginine 
uptake by vesicles in the presence or absence of a 
sodium gradient. In addition, N-ethylmaleimide 
(NEM), a sulfhydryl reactive agent that has been 
reported to inhibit transport via System y÷ and not 
via System y+L [29], caused a 55% reduction in 
L-arginine transport (Table 2). 
The uptake of [3H]-L-arginine by System y÷ 
reached a maximum by 5 min, and then slowly de- 
clined as the initial ion gradients were dissipated. In 
the absence of transmembrane ion gradients, uptake 
of [3H]-L-arginine into plasma membrane vesicles 
was highly diminished (Table 1). If the ion gradients 
are dissipated by the addition of saponin (50 p~g/ml), 
which renders the membranes highly permeable, in- 
travesicular [3H]-L-arginine rapidly effluxes from the 
plasma membrane vesicles (Fig. 1). The same effect 
is induced by the ionophore gramicidin (100 ~M), 
which dissipates both Na + and K ÷ gradients. The 
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Fig. 1. Transport of [3H]-L-arginine by plasma membrane vesi- 
cles. Transport assays were performed as described in Section 2. 
(a - - -A )  - vesicles (301xl) loaded with 140mM potassium 
phosphate, I mM MgSO 4, pH 6.8, diluted in 4701xl of 140mM 
NaC1 containing l mM MgSO 4 and [3H]-L-arginine; (©- - -©)  - 
the same only LiCI was substituted for NaC1; (A - - -A )  - 
saponin (50 ixg/ml) added to assay mixture at 5 rain; (0 -  - -0 )  - 
gramicidin (100 IxM) added to assay mixture at 5 min; (• - - -•  ) 
- monensin (5 IxM) added to assay mixture at 5 min; and ( • - -- • )  
- nigericin (5 laM) added to assay mixture at 5 min. Each point 
represents the mean of at least two experiments performed in 
triplicate. 
ionophore monensin (5 IxM), which dissipates primar- 
ily the Na ÷ gradient, has only a slight effect on 
[3H]-L-arginine transport, whereas the ionophore 
nigericin (51xM), which preferentially disrupts the 
K ÷ gradient, exhibits a much more profound effect 
(Fig. 1). 
The isolated plasma membrane vesicles used in 
these experiments were osmotically intact as demon- 
strated by the sensitivity of L-arginine uptake to 
osmotic pressure (Fig. 2). When the osmolarity of the 
uptake medium was increased, uptake of [3H]-L- 
arginine decreased. These results also provide strong 
evidence that [3H]-L-arginine was accumulating in 
the intravesicular space rather than simply binding to 
the membrane surface since the latter would not be 
expected to vary with the osmolarity of the external 
solution. 
3.2. Kinetics of high-affinity Na-independent arginine 
transport 
Uptake of [3H]-L-arginine by K+-loaded vesicles, 
diluted in Li-containing external solution, was found 
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Table 1 
Effects of the composition of the extra- and intravesicular solutions on [3H]-L-arginine uptake by plasma membrane v sicles derived from 
porcine PAEC a 
Extravesicular Intravesicular Condition [ 3 H]-L-arginine 
solution b solution c uptake 
(% of control) 
140 mM NaCl 140 mM K-phosphate 
140 mM LiC1 140 mM K-phosphate 
100 mM NaC1 100 mM LiCI 
40 mM K-phosphate 40 mM K-phosphate 
40 mM K-phosphate 40 mM K-phosphate 
40 mM Na-phosphate 40 mM Na-phosphate 
60 mM NaC1 60 mM NaC1 
100 mM NaSCN 140 mM LiCI 
40 mM NaC1 
100 mM NaSCN 140 mM NaCI 
40 mM NaC1 
Membrane potential is created by trans-membrane potassium 
gradient; Na-gradient is also present 
(control conditions) 100 
Membrane potential is created by trans-membrane potassium 
gradient; Na-gradient is absent 94 
Membrane potential is absent; only Na-gradient is created 7 
Membrane potential nd Na-gradient are absent 
Membrane potential (interior negative) is created 
by transmembrane gradient of the highly permeant thiocyanate 72 
anion (out > in). Na-gradient is present 
Membrane potential is created by trans-membrane 
gradient of thiocyanate anion. Na-gradient is absent 74 
Transport assays were carried out at 37°C with a [3H]-L-arginine concentration f 50 p.M as described under Section 2. Reactions were 
stopped at 3 min by dilution of plasma membrane v sicles into ice-cold external solutions of different compositions. Results in each case 
are means of at least two experiments performed in triplicate. [3H]-L-arginine uptake under control conditions was 276 4- 25 pmoles/mg 
bprotein/3 min. 
All extravesicular solutions also contained 1 mM MgSO 4 and were buffered with l0 mM HEPES-Tris to pH = 7.4. 
All intravesicular solutions also contained 1mM MgSO 4 and had pH = 6.8. 
to be saturable at concentrations ranging from 3 to 
400 IxM (Fig. 3). Analysis of the kinetic data from 
four separate experiments performed in triplicate, 
using an Eadie-Hofstee linear transformation, re- 
vealed a single high-affinity Na-independent trans- 
port system with a K m of (mean ___ standard error) 
130 _+ 14 IxM and a corresponding Vma x of (mean +_ 
standard error) 694_+ 65pmol /mg protein/30s at 
37°C. Reported values of K m for high affinity L- 
arginine uptake into intact endothelial cells lie in the 
6-304 txM range [13,15,16,30]. 
3.3. Driving force for L-arginine uptake 
To elucidate the nature of the driving force for 
L-arginine uptake, we measured [3H]-L-arginine 
transport into plasma membrane vesicles in the pres- 
ence of different ion gradients that were created by 
varying the composition of the extravesicular and 
intravesicular solutions (Table 1). [3H]-L-arginine up- 
take by plasma membrane vesicles was maximal in 
the presence of a sodium gradient and a membrane 
potential created by a transmembrane potassium gra- 
dient. The sodium gradient was not essential for 
maximal L-arginine transport because the substitution 
of Li + ions in the external solution for Na + ions 
induced only a small and insignificant reduction in 
[3H]-L-arginine uptake (Table 1). However, in the 
absence of a membrane potential, [3H]-L-arginine 
transport into plasma membrane vesicles did not oc- 
cur, irrespective of whether a sodium gradient existed 
(Table 1). A membrane potential (interior negative), 
created either by a potassium gradient directed out- 
side or a transmembrane gradient of the highly per- 
meant thiocyanate anion directed inside, induced ef- 
fective [3H]-L-arginine transport into plasma mem- 
brane vesicles in the presence as well as in the 
absence of a sodium gradient (Table 1). The rate of 
[3H]-L-arginine uptake was related in a linear manner 
to the value of the membrane potential created by the 
transmembrane thiocyanate gradient (Fig. 4). [3H]-L- 
arginine uptakes by plasma membrane vesicles were 
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Table 2 
Effect of L-leucine and NEM on [3H]-L-arginine uptake by 
plasma membrane vesicles derived from porcine PAEC ~ 
Extravesicular solution Intravesicular solution [3H]-L- 
uptake arginine 
140mM NaCI 140mM K-phosphate 
-leucine 293 + 8 
+ 100 p~M leucine 312 + 8 
140 mM LiC1 140 mM K-phosphate 
-leucine 284 + 22 
+ 100 p~M leucine 274 + 20 
140 mM NaC1 140 mM K-phosphate 
-NEM 293 + 8 
+ 0.2 mM NEM 131 _+2 b 
Transport assays were carried out at 37°C with a [3H]-L-arginine 
concentration of 50 p,M as described in Section 2. Reactions were 
stopped at 3min, and results are expressed as pmoles L- 
arginine/mg protein/3min. Results are from two experiments 
performed in triplicate. 
bp < 0.01 VS. NEM. 
comparable under approximately the same membrane 
potential created by potassium or thiocyanate ion 
gradients. 
3.4. Trans-stimulation f L-arginine influx in plasma 
membrane vesicles 
One of the properties of cationic amino-acid trans- 
port mediated by System y+ is the trans-stimulation 
of amino-acid uptake when the substrate concentra- 
tion is sufficiently high on the intracellular (or intra- 
vesicular) side of the membrane [12,31]. To study 
this particular feature of the transport system for 
L-arginine, we loaded plasma membrane vesicles with 
potassium phosphate buffer containing various con- 
centrations of L-arginine and then measured uptakes. 
The uptake of [3H]-L-arginine by vesicles loaded with 
L-arginine (trans-stimulated uptake) was compared to 
[3H]-L-arginine uptake by vesicles without intravesic- 
ular L-arginine (control uptake) (Fig. 5). A significant 
trans-stimulatory effect of intravesicular L-arginine 
emerged at an intravesicular concentration f 0.1 mM 
and reached a maximal value (increase of -- 40%) at 
an intravesicular concentration of 0.2raM. Further 
increases in L-arginine concentration inside the plasma 
membrane vesicles induced a gradual reduction in the 
[3H]-I:arginine accumulation i the vesicles, proba- 
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Fig. 2. Effect of the osmolarity of the external solution on 
[3H]-L-arginine uptake by plasma membrane vesicles. Transport 
assays were performed as described in Section 2 by diluting 
vesicles into the uptake medium containing additional concentra- 
tions of sucrose to increase osmolarity. The time of incubation 
with [3H]-L-arginine was 3 min. Each point represents the mean 
of two experiments performed in triplicate. 
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Fig. 3. Kinetics of Na-independent [3H]-L-arginine transport in 
plasma membrane vesicles isolated from porcine PAEC. Initial 
rates of [3H]-e-arginine uptake, V, were measured for 30s at 
37°C as described in Section 2 at various concentrations of 
L-arginine. All measurements were corrected for nonspecific 
[3H]-L-arginine uptake at each L-arginine concentration (0-time). 
The data represent mean values of one typical experiment with 
K m = 1591xM and Vma × = 700pmol/mg protein/30s. Inset: ac- 
companying Eadie-Hofstee plot of the data. 
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Fig. 4. Dependence of [3H]-L-arginine transport by plasma mem- 
brane vesicles on the inward gradient of thiocyanate anions. 
Membrane vesicles were loaded with 140mM NaCI+ l mM 
MgSO 4, in 10mM HEPES-Tris buffer (pH 7.4) as described in 
Section 2 and diluted into external solution containing labeled 
L-arginine and various concentrations of NaSCN. In the solutions 
with different concentrations of SCN- ions, NaSCN was substi- 
tuted for NaC1 so that the osmolarities of intra- and extravesicular 
solutions were the same. The pH of the external solutions was 
adjusted to 7.4 with 10mM HEPES-Tris. The incubation time 
with [3H]-L-arginine was 3 min, and the reaction was stopped by 
dilution in ice-cold external solution, followed immediately by 
filtration through GF/C membrane filters as described in Section 
2. Each point represents he mean_+ S.E.M. of three experiments 
performed in triplicate. 
bly due to leakage of unlabeled L-arginine from the 
vesicles that competed with extravesicular [3H]-L- 
arginine for binding sites on the transporter. Never- 
theless, [3H]-L-arginine uptake by plasma membrane 
vesicles loaded with 1 raM unlabeled L-arginine was 
higher ( = 20%) than that in control vesicles without 
L-arginine inside. The effect of trans-stimulation was 
observed in the presence of an inward-directed sodium 
membrane gradient (i.e. potassium phosphate buffer 
inside plasma membrane vesicles and 140mM 
NaSCN solution outside) as well as in the absence of 
this gradient (i.e. potassium phosphate buffer inside 
and LiC1 solution outside). It is noteworthy that we 
did not observe the trans-stimulatory effect of intrav- 
esicular L-arginine on [3H]-L-arginine accumulation 
in the presence of a membrane potential (created by 
external 140raM NaSCN) when a sodium phosphate 
buffer was substituted for intravesicular potassium 
phosphate buffer (Fig. 5). 
3.5. Modulation of L-arginine transport by amino 
acids, L-arginine analogs, ionophores, and potassium 
channel agonists and antagonists 
L-Arginine transport was stereospecific and was 
inhibited markedly by other cationic amino acids 
(L-lysine, L-ornithine and L-homoarginine) and by the 
cationic L-arginine analog NG-monomethyl-L- 
arginine (L-NMMA), which is a potent inhibitor of 
eNOS (Table 3). In contrast, neutral amino acids, 
including 0.1 mM and 1 mM L-leucine, and the neu- 
tral L-arginine analog inhibitors of eNOS, NG-nitro- 
L-arginine (L-NNA) and its methyl ester, L-NAME, 
were poor inhibitors. Monensin, one of the few 
ionophores known to selectively complex Na ions 
[32], induced significantly weaker inhibition of [3H]- 
L-arginine uptake in plasma membrane vesicles than 
nigericin, which complexes more readily with K + 
than Na +. Gramicidin, which dissipates both Na + 
and K + gradients, manifested the property of a strong 
~" 1.6 
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Fig. 5. Trans-stimulation of L-arginine transport by plasma mem- 
brane vesicles. [3H]-L-arginine uptake by plasma membrane vesi- 
cles loaded with potassium phosphate buffer + I mM MgSO 4 (pH 
6.8) containing different concentrations of L-arginine (O---O).  
[3H]-L-arginine uptake by plasma membrane v sicles loaded with 
sodium phosphate buffer plus 1 mM MgSO 4 containing different 
concentration f L-arginine (0-  --O). Uptakes were measured in
140mM NaSCN external solution. The data are expressed as a 
ratio of [3H]-L-arginine uptake in the presence of a given intrav- 
esicular L-arginine concentration (trans-stimulated uptake) to the 
uptake in control vesicles (no L-arginine inside). Each point 
represents the mean of at least three experiments performed in 
triplicate + S.E. 
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Table 3 
The effects of amino acids, L-arginine analogs, ionophores, and potassium channel agonists and antagonists on [3H]-L-arginine transport 
by plasma membrane vesicles a
Substance Concentration [3H]-L-arginine uptake (% of control) 
Cationic amino acids 
L-lysine 1 mM 3 + 2 d 
L-omithine I mM 5 _+ 4 d 
L-homoarginine 1 mM 5 ± 3 J 
Neutral amino acids 
L-leucine 0. I mM 108 + 7 
L-leucine 1 mM 94 _ 5 
L-glutamine 1 mM 92 + 6 
L-serine I mM 89 _+ 8 
L-arginine analogs b 
L-NMMA 100 IxM 14 + 6 d 
L-NNA 100 IxM 82 _-t- 10 
L-NAME 100 txM 88 + 11 
Cation ionophores 
gramicidin 100 IxM 19 + 5 d 
monensin 5 txM 78 ___ 2 J 
nigericin 5 ixM 25 + 6 d 
valinomycin 50 ~M 152 + 17 d 
H +-ionophores c 
CCCP 50 I~M 98 _+ 5 
FCCP 10 IxM 95 -t- 3 
K +-channel agon&ts 
diazoxide 400 txM 89 _+ 9 
pinacidil 500 IxM 87 _+ 7 
K +-channel antagonists 
tetraethylammonium chloride 20 I~M 74 + 4 o 
4-aminopyridine 500 I~M 78 + 3 d 
glibenclamide 10 IxM 72 _ 6 d 
~[3H]-L-arginine transport was assayed at 37°C as described under Section 2. Substances were added to incubation media, and 
[3H]-L-arginine uptake was initiated by the addition of plasma membrane vesicles. Reactions were stopped at 3 rain. Results are means of 
at least 6 assays in each case. Control uptake of [3H]-L-arginine was 283 _+ 22pmoles/mg protein/3 min (mean _+ S.E.M.). 
b L-NMMA - NG-monomethyl-L-arginine; L-NAME - NG-nitro-L-arginine methyl ester; t-NNA - NG-nitro-L-arginine. 
c CCCP - carbonyl cyanide m-chlorophenylhydrazone; FCCP - carbonyl cyanide p(trifluoromethoxy)phenyl-hydrazone. 
a p < 0.05 vs. control result. 
inhibi tor  o f  [3H]-L-arginine transport.  On the other 
hand, the K + ionophore  va l inomycin ,  which induces 
hyperpo lar izat ion at low external  potass ium concen-  
trations [33], caused a cons iderable  st imulat ion of  
[3H]-L-arginine uptake by p lasma membrane vesicles.  
The proton-conduct ing  ionophores,  CCCP and FCCP,  
had no effect on [3H]-L-arginine transport.  Because 
L-arginine transport  is very sensit ive to membrane 
potent ia l  [19,33-35] ,  which is largely supported by 
K ÷ gradients,  we assessed the effects o f  both act iva- 
tors and b lockers  o f  K+-channels  on [3H]-L-arginine 
uptake by vesicles.  Act ivators  o f  K+-channe ls  (di- 
azox ide and pinacidi l )  had no s igni f icant effect on 
[3H]-L-arginine uptake,  whereas b lockers  o f  K ÷- 
channels  ( te t raethy lammonium chlor ide,  4 -amino-  
pyr id ine and g l ibenc lamide)  caused decreases in 
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[3H]-L-arginine transport by plasma membrane vesi- 
cles. 
4. Discussion 
The present investigation was devoted to charac- 
terizing the uptake of [3H]-L-arginine by plasma 
membrane vesicles derived from PAEC. A question 
that arises in studies such as these is whether the 
observed interaction between [ 3H]-L-arginine and the 
vesicles represents uptake by the vesicles or merely 
binding to vesicle membranes. Two lines of evidence 
suggest hat, in our experiments, [3H]-L-arginine is 
taken up inside the vesicles. First, uptake of [3H]-L- 
arginine decreases when the intravesicular space 
shrinks upon addition of external sucrose (Fig. 2). 
This would not be expected to occur if [3H]-L-arginine 
were merely binding to vesicle membranes. Sec- 
ondly, the accumulated [3H]-L-arginine ffiuxed from 
the plasma membrane vesicles after treatment with 
the cholesterol-chelating detergent saponin (Fig. 1). 
The present study demonstrates that [ 3H]-L-arginine 
transport in plasma membrane vesicles is similar in 
many respects to L-arginine transport in cultured 
endothelial cells. For example, it is Na+-independent, 
sensitive to trans-stimulation, unaffected by proton- 
conducting ionophores, and selectively inhibited by 
cationic amino acids. In addition, L-arginine transport 
is sensitive to N-ethylmaleimide and is not affected 
by micromolar or millimolar concentrations of L- 
leucine. These transport properties are inherent to 
System y+ [12,20,29], which was recently cloned and 
expressed in Xenopus oocytes [18,36]. Our kinetic 
experiments, performed over a wide range of sub- 
strate concentrations, revealed only one population of 
L-arginine transporters with a K m ---1301xM. We 
[13] and Green et al. [15] have described an Na+-de - 
pendent ransport system for L-arginine in porcine 
pulmonary endothelial cells that is responsible for 
20-40% of total carrier-mediated transport in these 
cells. However, we did not find any evidence for the 
existence of this transport system in our plasma 
membrane vesicles. Although the reason for this is 
not clear, it may be related to the loss of membrane 
proteins belonging to this transport system secondary 
to isolation, purification, and storage of the mem- 
brane vesicle preparations. 
Our results support the observations of others 
[ 14,16,19,21,22] that L-arginine transport by endothe- 
lial cells is dependent on membrane potential. First, 
L-arginine transport into plasma membrane vesicles 
was not observed in the absence of membrane poten- 
tial (Table 1). Second, the accumulation of [3H]-L- 
arginine into plasma membrane vesicles was dis- 
rupted by the action of drugs that dissipate transmem- 
brahe potassium gradients (e.g. saponin, gramicidin, 
nigericin) (Fig, 1) and was stimulated by the action of 
the membrane-hyperpolarizing potassium ionophore 
valinomycin (Table 3). Because membrane potential 
is determined in a large part by the transmembrane 
potassium gradient, the question arises as to whether 
it is the membrane potential or the chemical concen- 
tration gradient for potassium that ultimately drives 
the uptake of L-arginine. In other words, is it possible 
that the System y + L-arginine transporter works as a 
K+/L-arginine xchanger? To test this possibility, we 
measured [3H]-L-arginine transport into plasma mem- 
brane vesicles under conditions where the membrane 
potential (interior negative) was created not by an 
outward potassium gradient but by an inward gradi- 
ent of the highly permeant thiocyanate anion (Table 
l, Fig. 4). Our results show that with a membrane 
potential, [3H]-L-arginine can accumulate in vesicles 
even in the absence of potassium ions. This clearly 
demonstrates that the primary driving force for L- 
arginine transport is the membrane potential. Addi- 
tional evidence in favor of this conclusion follows 
from our experiments with potassium channel antago- 
nists, which, by blocking potassium channels, would 
be expected to depolarize vesicular membranes and 
reduce [3H]-L-arginine uptake (Table 3). If potas- 
sium/L-arginine xchange were driving L-arginine 
uptake, then the use of potassium channel blockers 
would have been expected to increase intravesicular 
concentrations of potassium and, in turn, L-arginine 
influx, which did not occur. 
In addition to contributing to the membrane poten- 
tial that is the driving force for L-arginine influx, our 
results indicate that potassium ions play an important 
role in the phenomenon of trans-stimulation - i.e. the 
increased uptake of L-arginine in the presence of 
L-arginine on the opposite (trans) side of the mem- 
brane. Existing models of trans-stimulation predict 
that the conformational change of the carrier occurs 
much more rapidly in the presence of substrate and, 
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thus, the return of the transporter to the cis-conforma- 
tion is slow when the substrate concentration on the 
transmembrane side is low [37]. This, of course, will 
result in a low level of amino-acid influx (i.e. uptake) 
from the cis-side. In our experiments, we could not 
observe a trans-stimulatory effect of intravesicular 
L-arginine on [3H]-L-arginine uptake in the absence 
of intravesicular potassium ions (Fig. 5). The precise 
role that potassium ions play in trans-stimulation is 
not clear from our studies, but it is possible that the 
binding of potassium to the L-arginine transport pro- 
tein increases the affinity of the amino-acid recogni- 
tion site for L-arginine and promotes the reorientation 
of the loaded transporter f om the trans- to the cis-face 
of the membrane. Such a mechanism can explain the 
experimental observation that K +-depolarization acti- 
vates the efflux of pre-accumulated [3H]-L-arginine 
from endothelial cells only in the presence of extra- 
cellular substrate (unpublished observations). This 
property of the L-arginine transporter provides 
physiological protection against depletion of intra- 
cellular L-arginine since concentrations of extracellu- 
lar potassium that are lower than intracellular potas- 
sium will protect against efflux of intracellular L- 
arginine even during long periods of starvation. 
Because L-arginine transport is dependent upon 
membrane potential, which is supported by K ÷ gradi- 
ents, we tested the effects of both activators and 
blockers of K+-channels on [3H]-L-arginine uptake 
by plasma membrane vesicles. Contrary to our initial 
expectations, we did not observe increased [3H]-L- 
arginine uptake by vesicles treated with K+-channel 
agonists. However, this surprising result may support 
the concept that membrane potential is the driving 
force for L-arginine transport across cellular mem- 
branes. There are at least four types of endothelial 
K+-channels, two of which are voltage gated (in- 
wardly rectifying K+-channel and transient (A type) 
K+-channel) and two of which are ligand gated 
(Ca2+-dependent K+-channel and ATP-sensitive K ÷- 
channel). Under physiological conditions, the resting 
membrane potential of endothelial cells is determined 
by the activity of the inwardly rectifying K+-chan - 
nels, which are activated by hyperpolarization [38]. A 
physiologically important role of the inward rectifier 
K + current is to help set the resting membrane 
potential. Rapid hyperpolarization f endothelial cells 
induced by such stimulants as bradykinin [39], acetyl- 
choline [40], or substance P [41] is followed by a 
sustained epolarization due to the activation of the 
inward rectifier K+-channels. If the inward rectifier 
K÷-channels retain their properties in isolated plasma 
membrane vesicles, the addition of K÷-channel acti- 
vators will, after a short-term hyperpolarization, in- 
duce slight membrane depolarization and, as a result, 
no significant changes in [3H]-L-arginine uptake by 
vesicles. 
The results of these studies demonstrate hat plasma 
membrane vesicles isolated from cultured lung en- 
dothelial cells retain most, if not all, of the functional 
and pharmacological characteristics of the System y ÷ 
L-arginine transport. In addition, these studies demon- 
strate for the first time a specific role for potassium 
ions in the mechanism of L-arginine transport, partic- 
ularly in the phenomenon of trans-stimulation. We 
believe that this study represents a first important 
step toward a more detailed understanding of the 
molecular and mechanistic aspects of L-arginine 
transport. 
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